KLF4 suppresses HDACi induced caspase activation and the SAPK pathway by targeting p57(Kip2)

Nung Ky1, Chuan Bian Lim, Jinming Li

  • 1Nanyang Technological University, Singapore, Singapore.

Insights

Kruppel-like factor 4 (KLF4) unexpectedly inhibits apoptosis by blocking caspase cleavage and upregulating p57(Kip2). High KLF4 levels may cause cancer cells to resist HDAC inhibitor treatments.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Kruppel-like factor 4 (KLF4) is a transcription factor involved in cell differentiation and pluripotency.
  • KLF4 is highly expressed in various cancers, suggesting oncogenic and antiapoptotic roles.
  • The precise mechanisms of KLF4's function in cancer and apoptosis remain unclear.

Purpose of the Study:

  • To elucidate the role of KLF4 in apoptosis regulation, particularly during histone deacetylase inhibitor (HDACi) treatment.
  • To investigate KLF4's interaction with apoptotic pathways and its impact on cancer cell response to HDACi.

Main Methods:

  • Analysis of KLF4 induction during HDACi treatment.
  • Investigation of KLF4's effect on the extrinsic apoptosis pathway, including caspase cleavage.
  • Chromatin immunoprecipitation and reporter assays to assess KLF4 binding to the p57(Kip2) promoter.
  • Examination of KLF4's influence on the stress-activated protein kinase cascade and c-Jun phosphorylation.

Main Results:

  • KLF4 is induced by HDACi treatment and inhibits apoptosis by preventing caspase cleavage.
  • KLF4 directly binds to the p57(Kip2) promoter, leading to its transcriptional upregulation.
  • Upregulation of p57(Kip2) by KLF4 suppresses the stress-activated protein kinase cascade and c-Jun phosphorylation.
  • Cancer cells with high KLF4 expression may exhibit resistance to HDACi therapy.

Conclusions:

  • KLF4 possesses an unexpected antiapoptotic function in cancer cells.
  • KLF4 acts as a critical determinant of cell fate in response to HDACi-induced apoptosis.
  • These findings highlight KLF4's complex role in cancer and suggest therapeutic implications for HDACi treatment resistance.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...